X0306 4 2014-02-24 0000885725 BOSTON SCIENTIFIC CORP BSX 0001529708 Nanavaty Maulik ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 SVP & Pres, Neuromodulation Common Stock 2014-02-24 4 A 0 16919.0000 0.0000 A 98637.0000 D Common Stock 2014-02-24 4 M 0 2106.0000 0.0000 A 100743.0000 D Common Stock 2014-02-24 4 F 0 7161.0000 13.0800 D 93582.0000 D Deferred Stock Units 2014-02-24 4 A 0 13379.0000 0.0000 A 2019-02-24 Common Stock 13379.0000 13379.0000 D Deferred Stock Units 0.0000 2014-02-24 4 M 0 2106.0000 0.0000 D 2019-02-24 Common Stock 2106.0000 0.0000 D Performance Share Units 2014-02-24 4 A 0 17150.0000 0.0000 A 2015-12-31 2015-12-31 Common Stock 17150.0000 17150.0000 D Stock Option (Right to Buy) 13.0800 2014-02-24 4 A 0 31876.0000 0.0000 A 2024-02-24 Common Stock 31876.0000 31876.0000 D On February 28, 2011, the reporting person was awarded a target number of performance share units under the Company's 2011 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2013 and was subject to the completion of the concurrent three-year individual service period. On February 24, 2014, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. On February 28, 2013, the reporting person was awarded a target number of performance share units under the Company's 2013 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2013 adjusted free cash flow measured against its 2013 financial plan over the one-year performance period ending December 31, 2013 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2014, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole on December 31, 2015 upon the completion of the individual service period. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. /s/ Lee G. Giguere, Attorney-in-Fact 2014-02-26